Ronald M. Kurtz MD - 03 Aug 2021 Form 4 Insider Report for RxSight, Inc. (RXST)

Role: President & Chief Executive Officer, Director
Signature: /s/ Shelley Thunen, as Attorney-in-Fact
Issuer symbol: RXST
Transactions as of: 03 Aug 2021
Net transactions value: +$2,050,378
Form type: 4
Filing time: 05 Aug 2021, 19:27:47 UTC
Previous filing: 02 Aug 2021
Next filing: 13 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RXST	Common Stock	Purchase	$2,000,000	+125,000		$16.00	125,000	03 Aug 2021	Direct
transaction	RXST	Common Stock	Purchase	$50,378	+3,638	+0.45%	$13.85	804,610	05 Aug 2021	See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.
F2	Represents the weighted average share price of an aggregate total of 3,638 shares purchased in the price range of $13.50 to $14.00 by Cricklewood LP. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Remarks:

President & Chief Executive Officer